Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shin Nippon Biomedical Laboratories Ltd amends consolidated full-year outlook for FY 2014


Friday, 14 Feb 2014 01:00am EST 

Shin Nippon Biomedical Laboratories Ltd:Says the company lowered the consolidated full-year outlook for revenue to 16,913 million yen from 17,417 million yen for the fiscal year ending Mar. 2014.Sees a decrease of operating profit forecast to a loss of 749 million yen from 5 million yen.Sees an increased ordinary profit forecast to a loss of 397 million yen from a loss of 420 million yen.Sees an increased net profit forecast to a loss of 845 million yen from a loss of 950 million yen.Sees an increased earnings per share to a loss of 22.51 yen from a loss of 27.66 yen.Comments that the delay of domestic clinical business, unrealized efficiency of US pre-clinical business, as well as increase of research and development cost for translational research business are the main reasons for the forecast. 

Company Quote

810.0
12.0 +1.50%
31 Oct 2014